ArticleBiochemistry and biophysics reports2025

Evaluation of an anti-CD3 VHH and construction of an anti-CD3/anti-EGFR bispecific tandem VHH as a cancer cell targeting drug construct.

Takuya Asanuma et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.